BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20137764)

  • 1. The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil.
    Lal R; Sukbuntherng J; Luo W; Huff FJ; Zou J; Cundy KC
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):120-8. PubMed ID: 20137764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
    Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin enacarbil and morphine administered in combination versus alone: a double-blind, randomized, pharmacokinetic, and tolerability comparison.
    Chen C; Upward J; Arumugham T; Stier B; Davy M
    Clin Ther; 2015 Feb; 37(2):349-57. PubMed ID: 25467190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
    Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
    Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics and pharmacodynamics of gabapentin after administration of gabapentin enacarbil.
    Lal R; Sukbuntherng J; Luo W; Tovera J; Lassauzet ML; Cundy KC
    J Clin Pharmacol; 2013 Jan; 53(1):29-40. PubMed ID: 23400741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
    Chen D; Lal R; Zomorodi K; Atluri H; Ho J; Luo W; Tovera J; Bonzo D; Cundy K
    Clin Ther; 2012 Feb; 34(2):351-362.e3. PubMed ID: 22325733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine.
    Lal R; Sukbuntherng J; Luo W; Vicente V; Blumenthal R; Ho J; Cundy KC
    Br J Clin Pharmacol; 2010 May; 69(5):498-507. PubMed ID: 20573085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin.
    Cundy KC; Sastry S; Luo W; Zou J; Moors TL; Canafax DM
    J Clin Pharmacol; 2008 Dec; 48(12):1378-88. PubMed ID: 18827074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and food.
    Chen C; Cowles VE; Hou E
    J Clin Pharmacol; 2011 Mar; 51(3):346-58. PubMed ID: 20484610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of pregabalin controlled-release in healthy volunteers: effect of food in five single-dose, randomized, clinical pharmacology studies.
    Chew ML; Plotka A; Alvey CW; Pitman VW; Alebic-Kolbah T; Scavone JM; Bockbrader HN
    Clin Drug Investig; 2014 Sep; 34(9):617-26. PubMed ID: 25078976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin enacarbil in restless legs syndrome.
    Merlino G; Serafini A; Lorenzut S; Sommaro M; Gigli GL; Valente M
    Drugs Today (Barc); 2010 Jan; 46(1):3-11. PubMed ID: 20200691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
    Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
    Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I, single-dose study of the disposition of 14C-radiolabeled gabapentin enacarbil in healthy male volunteers.
    Lal R; Sukbuntherng J; Ho J; Cundy KC
    Int J Clin Pharmacol Ther; 2011 Feb; 49(2):109-15. PubMed ID: 21255527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin absorption: effect of mixing with foods of varying macronutrient composition.
    Gidal BE; Maly MM; Kowalski JW; Rutecki PA; Pitterle ME; Cook DE
    Ann Pharmacother; 1998 Apr; 32(4):405-9. PubMed ID: 9562133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
    Godfrey AR; Digiacinto J; Davis MW
    Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin enacarbil for treatment of restless legs syndrome in adults.
    Hayes WJ; Lemon MD; Farver DK
    Ann Pharmacother; 2012 Feb; 46(2):229-39. PubMed ID: 22298601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome.
    Merlino G; Serafini A; Young JJ; Robiony F; Gigli GL; Valente M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):91-102. PubMed ID: 19127491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms.
    Cowles VE; Gordi T; Hou SY
    Clin Drug Investig; 2012 Sep; 32(9):593-601. PubMed ID: 22775354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analyses of dose-exposure relationships for gabapentin following oral administration of gabapentin and gabapentin enacarbil.
    Chen C
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1809-17. PubMed ID: 23743781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.